A 32-year-old man from rural Maharashtra presents with a 3-month history of cough, fever, and night sweats. Chest X-ray shows cavitary lesions in the right upper lobe. Sputum smear microscopy is positive for acid-fast bacilli. He is started on standard first-line anti-TB therapy. After 2 months of treatment, repeat sputum smear microscopy remains positive despite good adherence. What is the most appropriate next step in management?

Explanation

## Clinical Context This patient has **microbiological failure** — persistent sputum positivity after 2 months of standard therapy despite documented adherence. This is a red flag for drug-resistant tuberculosis (DR-TB). ## Key Point: **Microbiological failure (smear-positive at 2 months) mandates drug susceptibility testing (DST) and consideration of second-line anti-TB drugs.** This is a cardinal indicator for suspected MDR-TB or XDR-TB. ## Management Algorithm ```mermaid flowchart TD A[TB patient on DOTS]:::outcome --> B{Sputum smear at 2 months}:::decision B -->|Negative| C[Continue standard therapy]:::action B -->|Positive| D[Microbiological failure]:::urgent D --> E[Send sputum for DST/CBNAAT]:::action E --> F{Drug resistance?}:::decision F -->|Susceptible| G[Reassess adherence & absorption]:::action F -->|MDR/XDR| H[Initiate second-line regimen]:::action H --> I[Longer duration + injectable + FQ]:::outcome ``` ## High-Yield Facts - **Microbiological failure** = Sputum smear or culture positive at 2 months or later during treatment - **Immediate action**: DST (phenotypic or CBNAAT/GeneXpert MTB/RIF for rapid rifampicin resistance detection) - **Standard first-line therapy** (HRZE) is ineffective if DR-TB is present - **Second-line regimen** for MDR-TB: typically includes an injectable (amikacin/streptomycin), a fluoroquinolone (levofloxacin/moxifloxacin), and oral agents (linezolid, bedaquiline, or para-aminosalicylic acid) - Duration: 20 months minimum for MDR-TB ## Clinical Pearl: **Do NOT continue first-line therapy or add a single fifth drug without DST results.** Monotherapy addition risks further resistance. Confirmed DR-TB requires a complete regimen redesign. ## Tip: In NEET PG exams, **persistent sputum positivity at 2 months = DST + second-line drugs.** This is tested frequently because it is a critical decision point in TB management.